Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

Anders Erik Astrup Dahm(University of Oslo), Per Morten Sandset(Oslo University Hospital), Frits R. Rosendaal(Leiden University Medical Center), Bjørn Bendz(Oslo University Hospital), Astrid van Hylckama Vlieg(Leiden University Medical Center), Rogier M. Bertina(Leiden University Medical Center)
Blood
May 20, 2003
10.1182/blood-2002-10-3188
Cited by 241

Related Papers

Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803